“The Cord Blood Transplantation (COBLT) Study: The First Two Years of Recruitment and Collection by the COBLT Cord Blood Banks”, in American Society for Blood and Marrow Transplantation Annual Meeting, Anaheim, CA, 2000.,
“Corneal crystals in nephropathic cystinosis: natural history and treatment with cysteamine eye drops”, Mol Gene Metab., vol. 71, pp. 100-20, 2000.,
“Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine”, J Infec Dis, vol. 181, pp. 11133-7, 2000.,
“Cytokine profiles in seronegative volunteers immunized with a recombinant canarypox and gp120 prime-boost HIV-1 vaccine. NIAID AIDS Vaccine Evaluation Group”, AIDS Res HumRetroviruses, vol. 14, pp. 1365-74, 2000.
“A Canarypox Vaccine Expressing Multiple Human Immunodeficiency Virus Type 1 Genes Given Alone or with Rgp120 Elicits Broad and Durable CD8+ Cytotoxic T Lymphocyte Responses in Seronegative Volunteers”, J Infec Dis, vol. 180, no. 2, pp. 290-298, 1999.,
“Cancer prevalence in Italian regions with local cancer registries”, Tumori, vol. 85, pp. 400-7, 1999.,
“A Case-Control-Study of Risk Factors for Homophiles Influenza Type B Disease in Navajo Children”, AM J Trop Med Hug, vol. 60, no. 2, pp. 263-266, 1999.,
“Center volume effects in pediatric renal transplantation. A report of the North American Pediatric Renal Transplant Cooperative Study”, Pediatr Nephrol, vol. 5, pp. 373-8, 1999.,
“Chronic dialysis in children and adolescents. The 1996 Annual Report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS)”, Pediatr Nephrol, vol. 13, pp. 404-17, 1999.
“Clinical and immuno-virologic characterization of the efficacy of stavudine, lamivudine, and indinavir in human immunodeficiency virus infection”, J Pediatric, vol. 135, pp. 675-82, 1999.,
“Comparative trial of Prograf™ (tacrolimus) in combination with azathiprine or mycophenolate mofetil vs. neoral (cyclosporine) with mycophenolate mofeitil after kidney transplantation”, 1999.,
“Comparison of mortality risks of dialysis and renal transplantation in children: A report of the North American Pediatric Cooperative Study (NAPRTCS)”, 1999.,
“The conversion of kidney transplant patients to tacrolimus from cyclosporine because of refractory rejection or significant cyclosporine toxicity”, 1999.,
“Chronic renal insufficiency in children and adolescents: The 1996 Annual Report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS)”, Pediatr Nephrol, vol. 12, pp. 328-37, 1998.,
“Clinical Trials Referral Resource. Clinical trials assessing quality of life”, Oncology, vol. 12, pp. 69-74, 1998.,
“Clinical Trials Referral Resource. Clinical trials for children with brain tumors”, Oncology, vol. 12, pp. 393-96, 1998.,
“Clinical Trials Referral Resource. Clinical Trials in Adult Acute Myelogenous Leukemia”, Oncology, vol. 12, pp. 224-27, 1998.,
“Cognitive functioning in children with renal failure and post transplantation: A report of the North American Pediatric Cooperative Study (NAPRTCS)”, 1998.,
“Cognitive Functioning in Children with Renal Failure and Post Transplantation: A Report of the North American Pediatric Cooperative Study (NAPRTCS)”, in Am Soc of Transpl Phys, Chicago, IL, 1998.
“Cord Blood Transplantation Study (COBLT): Cord Blood Bank Standard Operating Procedures”, J Hematother, vol. 7, pp. 521-561, 1998.,
“Cyclosporine to tacrolimus: effect on hypertension and lipid profiles in renal allografts”, Transplant Proc, vol. 30, pp. 1254-6, 1998.,
“Cytotoxic T cell and neutralizing antibody responses to human immunodeficiency virus type1 envelope with a combination vaccine regimen”, J Infec Dis, vol. 177, pp. 301-9, 1998.,